Conclusions | |
---|---|
Quality | |
Trial quality taken into account | [35, 37] |
Trial quality mentioned | [23, 24, 27, 33] |
Heterogeneity | |
Discussed | [27, 28, 30, 32, 34, 35, 37] |
Statistical Assessment | [23–35, 37] |
Cochran's Q test and I2 statistic | [23–35, 37] |
Clinical acknowledged | [24, 25, 32] |
Methodological acknowledged | [26, 33, 35] |